Pill will not surpass need for vaccination

• Governments are scrambling to secure supplies of an experimental anti-viral drug that is hoped will keep those most at risk of Covid-19 out of hospital and lower their chances of dying from the disease. But this development is no reason to sideline vaccinating as many people as possible